» Articles » PMID: 24444436

How Do Values Shape Technology Design? An Exploration of What Makes the Pursuit of Health and Wealth Legitimate in Academic Spin-offs

Overview
Specialty Social Sciences
Date 2014 Jan 22
PMID 24444436
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

By actively supporting cooperation between academia, clinical settings and industry, several policy initiatives assume that the two policy agendas of health and wealth can be reconciled through the development of health technology. Our goal in this article is to shed light on the way the concurrent pursuit of health and wealth operates in practice by examining the valuation schemes, actions and decisions that shaped technology development in three Canadian spin-offs. Drawing on the sociology of judgement, our analytical framework conceives of technology development as a purposive collective action that unfolds in a normatively heterogeneous context (one pervaded with both corporate and public service mission values and norms). Our qualitative empirical analyses explore four valuation schemes and their corresponding regimes of engagement that characterise why and how technology developers commit themselves to addressing certain clinical, interactional, organisational and economic concerns throughout the development process. Our discussion suggests that the ability to reconcile health and wealth goals is to be found in the moral repertoires that provide meaning to, and render coherent technology developers' participation in corporate activities driven by economic growth.

Citing Articles

Values of welfare technologies: a qualitative study of how employees in Swedish care for older adults understand and justify the use of new technology.

Lydahl D, Davidsson A BMC Health Serv Res. 2024; 24(1):1555.

PMID: 39639235 PMC: 11622466. DOI: 10.1186/s12913-024-12053-1.


Why is repositioning public health innovation towards a social paradigm necessary? A reflection on the field of public health through the examples of Ebola and Covid-19.

Niang M, Dupere S, Alami H, Gagnon M Global Health. 2021; 17(1):46.

PMID: 33853631 PMC: 8045578. DOI: 10.1186/s12992-021-00695-3.


The institutional workers of biomedical science: Legitimizing academic entrepreneurship and obscuring conflicts of interest.

Axler R, Miller F, Lehoux P, Lemmens T Sci Public Policy. 2018; 45(3):404-415.

PMID: 29937617 PMC: 6003607. DOI: 10.1093/scipol/scx075.


The Bright Elusive Butterfly of Value in Health Technology Development Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies".

Greenhalgh T, Fahy N, Shaw S Int J Health Policy Manag. 2018; 7(1):81-85.

PMID: 29325407 PMC: 5745872. DOI: 10.15171/ijhpm.2017.65.


Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies.

Lehoux P, Miller F, Daudelin G, Denis J Int J Health Policy Manag. 2017; 6(9):509-518.

PMID: 28949463 PMC: 5582437. DOI: 10.15171/ijhpm.2017.11.